Journal List > J Korean Diabetes Assoc > v.30(6) > 1062415

J Korean Diabetes Assoc. 2006 Nov;30(6):487-491. Korean.
Published online November 30, 2006.  https://doi.org/10.4093/jkda.2006.30.6.487
Copyright © 2006 Korean Diabetes Association
Acquired Generalized Lipodystrophy with Severe Insulin Resistant Diabetes Mellitus
Jung Min Lee, Tae Seo Sohn and Hyun Shik Son
Department of Internal Medicine, Division of Endocrinology and Metabolism, The Catholic University of Korea, Korea.
Received October 24, 2006; Accepted November 25, 2006.

Abstract

Acquired generalized lipodystrophy is a rare disease, and often follows autoimmune disease, prodromal infection, HIV infection. The clinical characteristics are generalized absence of fat, insulin resistance, diabetes mellitus, absence of ketosis, elevated basal metabolic rate, severe hypertriglyceridemia, and hepatomegaly. Here we experience and report a case of 16-year-old female patient who has clinical features of acquired generalized lipodystrophy with severe insulin resistant diabetes mellitus without any prodromal states.

Keywords: Diabetes mellitus; Hypertriglyceridemia; Lipodystrophy

Figures


Fig. 1
General appearance revealed a muscular hypertrophy, larger biacromial than bitrochanterian diameter, lack of subcutaneous fat on trunk and limbs, no development of breast.
Click for larger image


Fig. 2
MRI of the liver. Hepatomegaly and fatty changes were detected.
Click for larger image


Fig. 3
MRI of the thight. There ar no intramuscular fat deposit. But, bone marrow fat is preserved.
Click for larger image

References
1. Garg A. Lipodystrophies. Am J Med 2000;108:143–152.
2. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, report of 2 cases. Lancet 1946;1:724–731.
3. Beradinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab 1954;14:193–204.
4. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations; a new diencephaliic syndrome? Acta Paediatr 1959;48:555–574.
5. Garg A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F, Kocak N, O'Rahilly S, Taylor SI, Patel SB, Bowcock AM. A gene for generalized lipodystrophy syndrome 9q34. J Clin Endocrinol Metab 1999;84:3390–3394.
6. Anil K. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics 2002;31(1):21–23.
7. Mage J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J. BSCL Working Group. Identification of the gene altered in Beradinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001;28(4):365–370.
8. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000;105:271–278.
9. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785–789.
10. Song S. The role of increased liver triglyceride content: a culprit of diabetic hyperglycemia. Diabetes Metab Res Rev 2002;18(1):5–12.
11. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci 1997;94:4318–4323.
12. Haque WA, Shinomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin level in patients with lipodystrophies. J Clin Endocrinol Metab 2002;87(5):2395.
13. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999;48:1487–1492.
14. Arioglu E, Dencan-Morin J, Sebring N, Rother KI, Glottieb N, lieberman J, Kleiner DE, Reynolds J, Premkumar A, Summer AE, Hoofnagle J, Tyalor SI. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann inter Med 2000;133:263–274.
15. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;346:570–578.